Payments to Acquire Property, Plant, and Equipment in USD of Cardiff Oncology, Inc. from Q1 2011 to 2024

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Cardiff Oncology, Inc. quarterly and annual Payments to Acquire Property, Plant, and Equipment history and change rate from Q1 2011 to 2024.
  • Cardiff Oncology, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2024 was $80,000, a 900% increase year-over-year.
  • Cardiff Oncology, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $80,000, a 86% decline from 2023.
  • Cardiff Oncology, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $582,000, a 42% decline from 2022.
  • Cardiff Oncology, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $1,006,000, a 391% increase from 2021.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)

Cardiff Oncology, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $80,000 +$72,000 +900% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q1 2023 $8,000 -$163,000 -95% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024 2024 Q1
Q1 2022 $171,000 +$171,000 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q1 2021 $0 $0 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q1 2020 $0 -$5,274 -100% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q1 2019 $5,274 +$174 +3.4% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q1 2018 $5,100 -$6,352 -55% 01 Jan 2018 31 Mar 2018 10-Q 07 May 2019 2019 Q1
Q1 2017 $11,452 -$340,571 -97% 01 Jan 2017 31 Mar 2017 10-Q 08 May 2018 2018 Q1
Q1 2016 $352,023 +$104,926 +42% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017 2017 Q1
Q1 2015 $247,097 +$128,590 +109% 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016 2016 Q1
Q1 2014 $118,507 +$25,156 +27% 01 Jan 2014 31 Mar 2014 10-Q 05 May 2015 2015 Q1
Q1 2013 $93,351 -$4,658 -4.8% 01 Jan 2013 31 Mar 2013 10-Q 12 May 2014 2014 Q1
Q1 2012 $98,009 +$96,481 +6314% 01 Jan 2012 31 Mar 2012 10-Q 14 May 2013 2013 Q1
Q1 2011 $1,528 01 Jan 2011 31 Mar 2011 10-Q 15 May 2012 2012 Q1

Cardiff Oncology, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $80,000 -$502,000 -86% 01 Jan 2024 31 Dec 2024 10-K 27 Feb 2025 2024 FY
2023 $582,000 -$424,000 -42% 01 Jan 2023 31 Dec 2023 10-K 27 Feb 2025 2024 FY
2022 $1,006,000 +$801,000 +391% 01 Jan 2022 31 Dec 2022 10-K 29 Feb 2024 2023 FY
2021 $205,000 -$6,000 -2.8% 01 Jan 2021 31 Dec 2021 10-K 02 Mar 2023 2022 FY
2020 $211,000 +$143,378 +212% 01 Jan 2020 31 Dec 2020 10-K 24 Feb 2022 2021 FY
2019 $67,622 +$62,522 +1226% 01 Jan 2019 31 Dec 2019 10-K 25 Feb 2021 2020 FY
2018 $5,100 -$96,001 -95% 01 Jan 2018 31 Dec 2018 10-K 27 Feb 2020 2019 FY
2017 $101,101 -$722,382 -88% 01 Jan 2017 31 Dec 2017 10-K 06 Mar 2019 2018 FY
2016 $823,483 -$1,417,583 -63% 01 Jan 2016 31 Dec 2016 10-K 26 Feb 2018 2017 FY
2015 $2,241,066 +$1,877,776 +517% 01 Jan 2015 31 Dec 2015 10-K 15 Mar 2017 2016 FY
2014 $363,290 -$286,494 -44% 01 Jan 2014 31 Dec 2014 10-K 15 Mar 2017 2016 FY
2013 $649,784 +$375,704 +137% 01 Jan 2013 31 Dec 2013 10-K 10 Mar 2016 2015 FY
2012 $274,080 +$272,552 +17837% 01 Jan 2012 31 Dec 2012 10-K 12 Mar 2015 2014 FY
2011 $1,528 01 Jan 2011 31 Dec 2011 10-K 17 Mar 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.